Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 6,757-6,768 of 10,592
Drug study icon
Active Not RecruitingNCT05944952

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
Friends Research Institute, Inc.
Condition
Addiction
Device study icon
CompletedNCT05857852

Low-Intensity Focused Ultrasound for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
United States
Sponsor
University of Virginia
Condition
Addiction
Behavioral study icon
SuspendedNCT06013384

Low-Intensity Focused Ultrasound for Treatment-Resistant Depression

This study exists to see whether brain scans or other body measurements is workable and worth testing more broadly. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.

In United States
DepressionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Depression
Behavioral study icon
SuspendedNCT05259306

Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophrenia

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
SchizophreniaBehavioralFrom 21 Years to 80 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
Device study icon
Active Not RecruitingNCT06482762

Low-Intensity Focused Ultrasound of the Amygdala for Bipolarity

This study is looking at whether cognitive behavioural therapy can help people with Bipolar. Participants receive a study treatment and complete follow-up visits and assessments.

Remote / online
BipolarityDeviceFrom 18 Years to 64 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity
Drug study icon
CompletedNCT04597450

Lu AG06466 in people with PTSD (PTSD)

This study is completed in the United States. It focuses on PTSD.

In United States
PTSDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
H. Lundbeck A/S
Condition
PTSD
Drug study icon
CompletedNCT04959032

Lumateperone for the Prevention of Relapse in people with Schizophrenia

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

In United States
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States, Bulgaria, Poland, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT03249376

Lumateperone Monotherapy for Depression in bipolarity Conducted Globally

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, Bulgaria, Colombia, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity, Depression
Biological study icon
CompletedNCT02392182

Lung HIV Microbiome Project (Michigan Site)

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
University of Michigan
Condition
Addiction
Drug study icon
CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This study exists to explore whether the medication Patients could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Canada, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868452

Lurasidone - A 6-week Study of people with Bipolar I Depression (Add-on)

This study exists to explore whether the medication Patients could improve care and understanding. Researchers are trying to understand what the medication Patients could change in day-to-day care and decision-making.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Czechia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.